| 标题 |
HSR26-204: Baseline EORTC QLQ-C30 “Clinically Important” Symptom Burden Predicts Survival and Toxicity in CLL/SLL Across Randomized Ibrutinib Trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of the National Comprehensive Cancer Network 作者:Ahmad Y. Abuhelwa; Sara A. Almansour; Humaid O. Al-Shamsi; Ziad Abuhelwa; Mohamad A. Ziade; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)